neovascular glaucoma
Conditions
Interventions
Case series:intravitreal conbercept
Sponsors
Tianjin Eye Hospital
Eligibility
Sex/Gender
All
Age
18 Years to 82 Years
Inclusion criteria
Inclusion criteria: 1. patients whose underlying diseases were DR, CRVO, carotid artery stenosis or occlusive disease; 2. patients who did not have PRP before; 3. patients who were 18 to 85 years old; 4. patients who underwent intravitreal injection with a visual acuity = hand motion, or the visual acuity of patients with enucleation had no light perception; 5. patients with an IOP >21 mmHg and under the maximum dose of antiglaucoma medications; 6. patients with iris or angle neovascularization; 7. patients with or without pupillary pigment epithelium.
Exclusion criteria
Exclusion criteria: 1. NVG combined with ocular tumours or uveitis; 2. severe cardiovascular and cerebrovascular diseases; 3. patients who had recent active inflammation of the eye; 4. patients who failed to complete the scheduled follow-ups for various reasons.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Best-corrected visual acuity;Intraocular pressure;anti-glaucoma medications;Vascular endothelial growth factor;Transforming growth factor-ß1;Placenta growth factor;Histopathological analysis of trabeculectomy specimens;Postoperative complications; | — |
Countries
China
Contacts
Public ContactJin Yang
Tianjin Eye Hospital
Outcome results
None listed